Neck Circumference and the Development of Cardiovascular Disease Risk Factors in the Framingham Heart Study by Preis, Sarah Rosner et al.
 
Neck Circumference and the Development of Cardiovascular
Disease Risk Factors in the Framingham Heart Study
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Preis, Sarah Rosner, Michael J. Pencina, Ralph B. D’Agostino,
James B. Meigs, Ramachandran S. Vasan, and Caroline S. Fox.
2013. “Neck Circumference and the Development of
Cardiovascular Disease Risk Factors in the Framingham Heart
Study.” Diabetes Care 36 (1): e3. doi:10.2337/dc12-0738.
http://dx.doi.org/10.2337/dc12-0738.
Published Version doi:10.2337/dc12-0738
Accessed February 19, 2015 3:12:02 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879566
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAOBSERVATIONS
Neck Circumference
and the Development
of Cardiovascular
Disease Risk Factors
in the Framingham
Heart Study
U
pper-body subcutaneous adipose
tissue, estimated by neck circum-
ference (NC), is a unique fat depot
that may confer additional risk for meta-
bolic risk factors over generalized and
central adiposity (1). Using a prospective
study design, we now evaluate whether
NC improves the prediction of incident
cardiovascular disease risk factors over
BMI and waist circumference (2).
Framingham Heart Study participants
(n 5 2,732; 54% women; mean age, 57
years) were followed for ;10 years (1995–
2008)forthedevelopmentoftype2diabetes
(fastingplasmaglucose$126mg/dLortreat-
ment), hypertension, low HDL cholesterol
(,40mg/dL,men;,50mg/dL,women),
and high triglycerides ($150 mg/dL
or lipid treatment). NC, BMI, and waist
circumference were standardized within
each sex to a mean of zero and an SD of
one. Logistic regression models, adjusted
forage,sex,andsmoking,wereusedtotest
the association between 1 SD increment of
NC with each outcome. C-statistics were
calculated to assess the impact of adding
NC to baseline models, and the net re-
classiﬁcation improvement (NRI) statistic
was calculated to assess risk reclassiﬁcation
improvement (low, 0–1.9%; medium, 2.0–
7.9%; high, $8% risk categories) (3,4).
Inbaselinemodels,NCwasassociated
(P,0.05)withalloutcomes.Afterfurther
adjustment for BMI and waist circumfer-
ence, NC remained associated only with
type 2 diabetes (n 5 182, odds ratio [OR]
5 1.57, 95% CI [1.24–1.98], P 5
0.0002). In this model, the OR for BMI
was 1.03 (95% CI [0.73–1.45], P 5
0.88), and the OR for waist circumference
was 1.48(95% CI[1.05–2.10], P50.03).
Additional adjustment for baseline fasting
blood glucose resulted in an OR for NC of
1.42 (95% CI [1.09–1.86], P 5 0.01).
When NC was added to a model
containing an established type 2 diabetes
risk score (5), the OR for type 2 diabetes
was1.36(95%CI[1.12–1.66],P50.002),
and the NRI was 10.2% (P , 0.0001).
WhenNCwasaddedtoamodelcontaining
the individual clinical characteristics used
toderivethetype2diabetesriskscore(age,
sex, parental history of type 2 diabetes,
BMI, hypertension, HDL cholesterol, and
fastingplasmaglucose),theORwassimilar
(OR1.53,95%CI[1.22–1.92],P50.0003).
NC had a stronger effect on the
incidence of type 2 diabetes in women
(OR 5 2.77, 95% CI [2.18–3.53], P ,
0.0001) compared with men (OR 5
1.76, 95% CI [1.43–2.15], P , 0.0001)
(Pinteraction 5 0.006).
For type 2 diabetes, the addition of
NC to a model containing baseline co-
variates and BMI resulted in a change in
the C-statistic from 0.743 to 0.766 (P 5
0.004) and an NRI of 7.4% (P 5 0.01).
When NC was added to a model with base-
linelevelsoffastingplasmaglucoseandBMI,
theC-statisticincreasedfrom0.885to0.891
(P 5 0.01), and the NRI was 4.5%
(P 5 0.03). Similar results were observed
when waist circumference was substituted
for BMI. When NC was added to a model
with BMI and waist circumference, the
C-statistic increased from 0.754 to 0.772 (P
5 0.01), and the NRI was 4.9% (P 5 0.10).
NC is associated with incident type 2
diabetes and a clinically meaningful im-
provement in the NRI. Our results are
limitedbythesinglefastingplasmaglucose
measure and the exclusion of those who
did not return for follow-up. Whether
measurement of NC improves type 2 di-
abetes prediction over traditional adiposity
measures warrants further investigation.
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